“…IPC-induced hypoalgesia may be governed by endogenous substances that have antinociceptive effects on pain pathways. Metabolic mediators including adenosine, bradykinin, opioids, and endocannabinoids–all of which are involved in pain signalling during exercise ( Sgherza et al, 2002 ; Murase et al, 2010 ; Aguiar et al, 2020 ; Hughes and Patterson, 2020 ; Hughes et al, 2021 )—have been purported to contribute to the protective response to RIPC ( Lee et al, 1996 ; Tomai et al, 1999 ; Cohen et al, 2000 ; Schoemaker and van Heijningen, 2000 ; Dickson et al, 2002 ; Patel et al, 2002 ; Hajrasouliha et al, 2008 ). Furthermore, the endogenous release of some of these autacoids is thought to modulate the stimulation and signalling of group III/IV afferents ( Amann et al, 2009 , Amann et al, 2011 ; Bouffard et al, 2021 ).…”